Ni-Cheng Liang is a Respiratory physician. OpenAlex indexes 14 publications with 219 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 W Arbor Dr
San Diego, CA 921039000
Telephone
858-657-7118Registry record last updated 19 Sept 2017.
Industry payments
50 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year202522 payments
- Grifols USA, LLCProgram year202514 payments
- GENZYME CORPORATIONProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
72.3%Corticosteroid41.3%Trelegy Ellipta47%Breo Ellipta12%Breztri Aerosphere10%Arnuity Ellipta9%Fluticasone Propionate7%Symbicort4%Breyna4%Budesonide-Formoterol Fumarate3%Qvar Redihaler2%Fluticasone Propionate Hfa1%Pulmicort Flexhaler1%Part D<11 patientsbeta2-Adrenergic Agonist18.7%Albuterol Sulfate Hfa88%Ventolin Hfa10%Serevent Diskus3%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
12%Corticosteroid9.4%Prednisone100%Part D≥118 patientsH2 blocker2.1%Famotidine100%Part D≥29 patients+ 1 more class in this area
Anti-infectives
7.7%Tetracycline-class Drug4.2%Doxycycline Hyclate100%Part D≥82 patientsMacrolide Antimicrobial2%Azithromycin100%Part D≥34 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effects of atherosclerotic plaque characteristics on haemodynamics during interventional robot diagnosis and treatment
International Journal of Biomedical Engineering and Technology
2025 - Mindfulness for Those with COPD, Asthma, Lung Cancer, and Lung Transplantation
American Journal of Respiratory and Critical Care Medicine
2020 - Mindfulness for those with COPD, Asthma, Lung Cancer and Lung Transplantation
American Journal of Respiratory and Critical Care Medicine
2020 - Cardiac Ct Can Be Used To Diagnose And Monitor The Thoracic Vertebral Fractures, Osteoporosis And Coronary Artery Atherosclerosis In Patients With Rheumatoid Arthritis
Journal of cardiovascular computed tomography
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”